Log In Sign up
The largest database of trusted experimental protocols

Corn oil c8267

Manufactured by Merck Group
Visit Supplier

Corn oil (C8267) is a refined vegetable oil extracted from the germ of corn kernels. It is a clear, pale yellow liquid with a mild, nutty flavor. The product is suitable for various laboratory applications that require a high-quality, plant-based oil.

Automatically generated - may contain errors

Lab products found in correlation

Angiotensin 2 a9525 50mg, by Merck Group (2 mentions) Anti cd4 antibody 183685, by Abcam (2 mentions) Anti troponin t antibody ms 295, by Thermo Fisher Scientific (2 mentions) Anti cd3 antibody mca1477t, by Bio-Rad (2 mentions) Anti myeloperoxidase mpo antibody a0398, by Agilent Technologies (2 mentions) Anti cd8 antibody, by Cell Signaling Technology (2 mentions)

Spelling variants of this product

Corn oil (720 citations) C8267 (87 citations) Corn oil (C8267‐500ML, (2 citations)

2 protocols using corn oil c8267

1

Pharmacological Interventions in Cardiovascular Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Osmotic mini-pumps (Alzet, model 2004) were used for drug delivery. Angiotensin II (A9525–50MG), phenylephrine hydrochloride (P6126–10G), tamoxifen (T5648–1G), and corn oil (C8267) were obtained from Millipore Sigma. Picro Sirius Red Stain Kit (ab150681), Anti-Fibroblast activation protein, alpha antibody (ab207178), anti-GFP antibody (ab6673), and anti-CD4 antibody (183685) were obtained from Abcam. Anti-Vimentin antibody (#9854) anti-F4/90 antibody (#70076), anti-CD19 antibody (#90176), and anti-CD8 antibody (#98941) were obtained from Cell Signaling Technology. Anti-Troponin T antibody (MS-295) was obtained from ThermoFisher Scientific. Anti-CD3 antibody (MCA1477T) was obtained from Bio-Rad Laboratories. Anti-Myeloperoxidase (MPO) antibody (A0398) was obtained from Dako/Agilent. Sterile saline (0.9% sodium chloride, 00409488850) was obtained from Hospira (Lake Forest, IL).
Aghajanian H., Kimura T., Rurik J.G., Hancock A.S., Leibowitz M.S., Li L., Scholler J., Monslow J., Lo A., Han W., Wang T., Bedi K., Morley M.P., Saldana R.A., Bolar N.A., McDaid K., Assenmacher C.A., Smith C.L., Wirth D., June C.H., Margulies K.B., Jain R., Puré E., Albelda S.M, & Epstein J.A. (2019). Targeting Cardiac Fibrosis with Engineered T cells. Nature, 573(7774), 430-433.
+ Open protocol
+ Expand
2

Pharmacological Interventions in Cardiovascular Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Osmotic mini-pumps (Alzet, model 2004) were used for drug delivery. Angiotensin II (A9525–50MG), phenylephrine hydrochloride (P6126–10G), tamoxifen (T5648–1G), and corn oil (C8267) were obtained from Millipore Sigma. Picro Sirius Red Stain Kit (ab150681), Anti-Fibroblast activation protein, alpha antibody (ab207178), anti-GFP antibody (ab6673), and anti-CD4 antibody (183685) were obtained from Abcam. Anti-Vimentin antibody (#9854) anti-F4/90 antibody (#70076), anti-CD19 antibody (#90176), and anti-CD8 antibody (#98941) were obtained from Cell Signaling Technology. Anti-Troponin T antibody (MS-295) was obtained from ThermoFisher Scientific. Anti-CD3 antibody (MCA1477T) was obtained from Bio-Rad Laboratories. Anti-Myeloperoxidase (MPO) antibody (A0398) was obtained from Dako/Agilent. Sterile saline (0.9% sodium chloride, 00409488850) was obtained from Hospira (Lake Forest, IL).
Aghajanian H., Kimura T., Rurik J.G., Hancock A.S., Leibowitz M.S., Li L., Scholler J., Monslow J., Lo A., Han W., Wang T., Bedi K., Morley M.P., Saldana R.A., Bolar N.A., McDaid K., Assenmacher C.A., Smith C.L., Wirth D., June C.H., Margulies K.B., Jain R., Puré E., Albelda S.M, & Epstein J.A. (2019). Targeting Cardiac Fibrosis with Engineered T cells. Nature, 573(7774), 430-433.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!